Sean T. Moriarty - 27 Feb 2026 Form 4/A - Amendment Insider Report for STEPAN CO (SCL)

Role
VP & GM Surfactants
Signature
/s/ James A. Hart, Attorney-in-Fact for Sean T. Moriarty
Issuer symbol
SCL
Transactions as of
27 Feb 2026
Net transactions value
$0
Form type
4/A - Amendment
Filing time
05 Mar 2026, 18:11:06 UTC
Date Of Original Report
04 Mar 2026
Previous filing
19 Feb 2026
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Moriarty Sean Thomas VP & GM Surfactants 1101 SKOKIE BOULEVARD, SUITE 500, NORTHBROOK /s/ James A. Hart, Attorney-in-Fact for Sean T. Moriarty 05 Mar 2026 0001716333

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCL Common Stock Award +57 +0.4% $52.51* 14,205 27 Feb 2026 Direct
holding SCL Common Stock 4,478 27 Feb 2026 By ESOP II Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCL Stock Appreciation Right Award +6,440 $0.000000* 6,440 02 Mar 2026 Common Stock 6,440 $17.47 Direct F1, F2
transaction SCL Performance Shares Award +2,247 $0.000000* 2,247 02 Mar 2026 Common Stock 2,247 Direct F3, F4
transaction SCL Restricted Stock Units Award +4,495 $0.000000* 4,495 02 Mar 2026 Restricted Stock Units 4,495 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vest ratably over three years beginning on the date shown.
F2 The Reporting Person's Form 4 filed on March 4, 2026 included an incorrect Stock Appreciation Right amount which has been corrected herein.
F3 Each performance share represents a contingent right to receive one share of Stepan Company common stock.
F4 The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2028.
F5 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.